Marie Cook, 49, from east London, who is prescribed Mounjaro on the NHS to treat her type 2 diabetes contacted Your Voice, Your BBC News to say she was also running out of the drug
(Wegovy, Mounjaro & the New Pill, 2026) Updated 22/06/26 Based on the available clinical evidence, Mounjaro (tirzepatide) and Wegovy (semaglutide) are both well tolerated, but most people find Mounjaro causes fewer gastrointestinal side effects at comparable doses, with lower rates of nausea and a higher likelihood of completing treatment
By activating this pathway, Semaglutide slows digestion and decreases the amount of glucose released by the liver
Home Selecting the correct needle size is an essential aspect of administering injections safely, effectively, and comfortably
Spencer Fane attorneys Beth Siemer and Brian Malkins article, FDA and Novo Nordisk Warned of GLP-1 Telehealth Compounding Takedown